• MVC Activates RhoA/ROCK1 to Disrupt Tight Junctions and Aid

  2026-06-29

  Ren et al. (2025) reveal a direct interaction between the Minute Virus of Canines (MVC) VP2 protein and ROCK1, activating the RhoA/ROCK1/MLC2 pathway to disrupt tight junctions and facilitate viral entry via occludin. This mechanistic insight identifies new antiviral targets within RhoA signaling and suggests translational strategies for viral and epithelial barrier research.

• Dissecting Drug-Induced Cell Death: Insights from MEDUSA Scr

  2026-06-28

  The reference study introduces MEDUSA, a new simulation-assisted framework for functional genomic screens that separates drug-induced cell death from growth effects, revealing key genetic regulators of lethality. This approach clarifies mechanisms underlying both apoptotic and non-apoptotic death, with significant implications for targeted drug development and interpretation of chemo-genetic screens.

• Curcumin Inhibits Endothelial Pyroptosis via Caspase-1 Pathw

  2026-06-27

  This study demonstrates that curcumin protects human umbilical vein endothelial cells (HUVECs) from hydrogen peroxide-induced pyroptosis by targeting NLRP3 inflammasome activation and caspase-1 signaling. The findings provide mechanistic insight into endothelial dysfunction and offer a foundation for selective caspase-1 inhibition in inflammation research.

• Applied Oncology Workflows with RG7388: Selective MDM2 Antag

  2026-06-26

  RG7388 stands out as a highly potent, selective MDM2 antagonist for activating the p53 pathway and inducing apoptosis in cancer cells with wild-type p53. This article unpacks advanced experimental workflows, protocol optimization, and troubleshooting strategies for maximizing the translational impact of RG7388, backed by the latest mechanistic insights.

• PR-619 in Ubiquitination Pathway Research: Mechanistic Insig

  2026-06-26

  Explore how PR-619, a potent deubiquitylating enzymes inhibitor, enables advanced ubiquitination pathway research. This article delivers mechanistic depth and translational context beyond standard protocols, with direct insight from recent epigenetic oncology breakthroughs.

• Breast Cancer Relies on MCL-1’s Canonical Anti-Apoptotic Fun

  2026-06-25

  A recent study clarifies that breast cancer cell survival is critically dependent on the canonical anti-apoptotic activity of MCL-1, rather than non-apoptotic functions. These findings refine the mechanistic basis for apoptosis-targeted therapies and highlight the importance of BCL-2 family interactions in breast cancer biology.

• 3-Bromopyruvate and Cetuximab Synergy in CRC: Overcoming Res

  2026-06-25

  This study demonstrates that combining 3-bromopyruvate with cetuximab induces ferroptosis, autophagy, and apoptosis in cetuximab-resistant colorectal cancer models. The findings highlight new mechanistic pathways for reversing resistance and suggest practical intervention points for translational cancer research.

• FLT3-ITD Mislocalisation Drives ADC Resistance in AML Cells

  2026-06-24

  This study uncovers how mislocalisation of the FLT3-ITD receptor in MV4-11 acute myeloid leukaemia cells impairs lysosomal trafficking of antibody-drug conjugates, reducing their cytotoxic efficacy. The findings have direct implications for ADC design and underscore the need to optimize intracellular trafficking for improved therapeutic outcomes.

• Modeling HSV-1 Latency in Human Sensory Neurons from hiPSCs

  2026-06-23

  This study establishes and validates a scalable platform for differentiating human inducible pluripotent stem cells (hiPSCs) into functional sensory neurons, enabling robust modeling of herpes simplex virus 1 (HSV-1) latency and reactivation. The system recapitulates key features of human neuronal infection, addressing longstanding limitations of animal models and opening new avenues for investigating virus-host interactions.

• Z-VAD-FMK in Apoptosis Inhibition: Protocols & Advanced Use-

  2026-06-23

  Harness Z-VAD-FMK’s precision as a pan-caspase inhibitor for robust dissection of apoptosis and cell death pathways. Discover optimized workflows, experimental troubleshooting, and real-world insights that differentiate this tool in complex cellular models.

• Catalpol Counters Triptolide Hepatotoxicity via SIRT1/HIF-1α

  2026-06-22

  This study demonstrates that Catalpol effectively ameliorates triptolide-induced liver injury by restoring glucose metabolism and reducing oxidative stress through SIRT1-mediated deacetylation of HIF-1α. The findings support Catalpol as a mechanistically validated tool for investigating drug-induced hepatotoxicity and metabolic dysfunction.

• Flubendazole in Autophagy Modulation: Protocols and Pitfalls

  2026-06-22

  Flubendazole (methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate) is emerging as a benchmark autophagy activator for advanced cancer biology and neurodegenerative research. Explore optimal workflows, troubleshooting insights, and unique comparative advantages that set this DMSO-soluble compound apart for robust autophagy signaling pathway investigations.

• Amiloride (MK-870): Precision Workflows in Sodium Channel Re

  2026-06-21

  Amiloride (MK-870) unlocks precision for sodium channel research and cellular endocytosis modulation, bridging ion transport discovery with translational disease modeling. This guide details optimized protocols, troubleshooting strategies, and experiment design insights leveraging APExBIO’s gold-standard compound.

• Norovirus Hijacks NINJ1 for Selective NS1 Protein Secretion

  2026-06-20

  This study uncovers how murine norovirus co-opts the membrane protein NINJ1 to selectively secrete the viral NS1 protein via a non-canonical pathway, while also mediating bulk release of cellular DAMPs. These findings clarify a new dimension of host-virus interactions and reveal potential targets for modulating programmed cell death and immune evasion.

• Oteseconazole (VT-1161): Advanced Antifungal Research Workfl

  2026-06-19

  Oteseconazole (VT-1161) enables highly selective, potent inhibition of Candida species, including fluconazole-resistant strains, with minimal off-target effects. This guide details optimized protocols, troubleshooting strategies, and new insights from recent research for robust antifungal assay development.

551 records 13/37 page Previous Next First page 上5页 1112131415 下5页 Last page